Stock Events

Stock Events

C4 Therapeutics (CCCC) Q3 2024 Earnings

1AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.69

-0.54

-0.4

-0.26

Details

Expected EPS

-0.364371

Actual EPS

-0.26

Surprise EPS

0.1

Surprise Percent

+28.64%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.26 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.